Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 21, 2025
Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transition for Three New Spider Silk Production Strains
GlobeNewswire
·
July 21, 2025
ANN ARBOR, Mich., July 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the successful completion of the first rearing cycles for its three newest …
SchoolAI's Deep Canvas Integration Helps Educators Reach Every Student, Every Day
GlobeNewswire
·
July 21, 2025
LEHI, Utah, July 21, 2025 (GLOBE NEWSWIRE) -- At InstructureCon 2025, SchoolAI unveiled a significant enhancement to its integration with Canvas, the most widely adopted Learning Management System in North America. The deeper Canvas integration, rolling …
Rogers Announces Upsizing and Results of its Cash Tender Offers for Canadian Dollar Debt Securities
GlobeNewswire
·
July 21, 2025
TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) announced (i) the release of the results of its previously announced separate offers (the “Offers”) to purchase for cash up …
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
GlobeNewswire
·
July 21, 2025
Approval is based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity EC approval follows positive CHMP opinion, MHRA conditional marketing …
Rogers Announces Results and Upsize of its Cash Tender Offers for Eight Series of U.S. Dollar Debt Securities
GlobeNewswire
·
July 21, 2025
TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) announced (i) the release of the results of its previously announced eight separate offers (the “Offers”) to purchase for …
Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
GlobeNewswire
·
July 21, 2025
MRT-8102 Phase 1 study includes single and multiple ascending dose cohorts in healthy volunteers and is designed to evaluate safety, pharmacokinetics, NEK7 protein degradation, and other key downstream pharmacodynamic markers; initial results anticipated …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
July 21, 2025
Nokia Corporation Stock Exchange Release 21 July 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 11 148 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia' …
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US
GlobeNewswire
·
July 21, 2025
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill combination of three medicines, including two doses that are …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
July 21, 2025
Nokia Oyj Pörssitiedote 21.7.2025 klo 14.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 11 148 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …
Dataprana Launches New Energy Division to Expand Its Data Infrastructure Portfolio
GlobeNewswire
·
July 21, 2025
AVENTURA, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- Dataprana, Inc. (“Dataprana”) is broadening its services with the launch of Prana Energy, a new division with a sole focus of expanding the company’s infrastructure portfolio through strategic land and …
BioCryst to Report Second Quarter 2025 Financial Results on August 4
GlobeNewswire
·
July 21, 2025
RESEARCH TRIANGLE PARK, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2025 financial results on Monday, August 4, 2025. BioCryst management will host a …
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
GlobeNewswire
·
July 21, 2025
PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss financial results for the …
DIFI Consortium Calls for Presentations & Announces Date of 2025 Workshop at MILCOM
GlobeNewswire
·
July 21, 2025
PISCATAWAY, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- The Digital Intermediate Frequency Interoperability (DIFI) Consortium announced that its 2025 DIFI Workshop: The Digital Transformation of SATCOM will take place on October 6th during MILCOM 2025, in Los …
Tonix Pharmaceuticals Announces the Launch of the “Move Fibro Forward” Campaign to Bring Awareness to Individuals Impacted by Fibromyalgia
GlobeNewswire
·
July 21, 2025
CHATHAM, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that Tonix Medicines, Inc., its commercial subsidiary, launched the Move Fibro Forward campaign …
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
GlobeNewswire
·
July 21, 2025
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome from …
BTCS Inc. ETH and Cash Market Value Now $242 Million
GlobeNewswire
·
July 21, 2025
Agrees to issue approximately $10 Million Convertible Notes at $13 per share, a 198% premium to July 18 close $189 million raised year-to-date through hallmark DeFi/TradFi Accretion Flywheel strategy SILVER SPRING, MD, July 21, 2025 (GLOBE NEWSWIRE) -- …
Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September
GlobeNewswire
·
July 21, 2025
IND cleared for the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe psoriasis, with initial data expected 2H 2026 Interim Phase 1 data and further details on EVERLAST-A study design to be shared in an oral presentation at EADV in September …
BioXcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package in Support of Potential Label Expansion for IGALMI®
GlobeNewswire
·
July 21, 2025
Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia Pre-Supplemental New Drug Application meeting with FDA scheduled for August 20, 2025 NEW …
NewGen Subsidiary Signs Memorandum of Understanding with Prominent UAE Real Estate Developer
GlobeNewswire
·
July 21, 2025
The agreement with BNW Real Estate Development LLC positions NewGenDigital to maximize the profitability of its recently acquired plot of land in the UAE Potential net return for the project is estimated to be as high as US$67 million per a feasibility …
SYNO International (SNI) Reaches Strategic Agreement with Indonesian Government, Achieves Breakthrough in the U.S., and Expands Global Presence
GlobeNewswire
·
July 21, 2025
New York, NY, July 21, 2025 (GLOBE NEWSWIRE) -- Recently, SYNO International (SNI) co-hosted the Jakarta Investment Summit in collaboration with Indonesian government agencies. This summit was not just an investment event; it served as a vital bridge …